🎍CDC Rescinds Lucky Bamboo Import Embargo
Based on a review of existing import requirements, CDC has determined that the import restrictions for Dracaena (Lucky Bamboo) shipped in standing water are no longer necessary to protect the public's health and should therefore be rescinded. Accordingly, effective immediately, CDC is rescinding its embargo on importation of Dracaena Shipments in Standing Water (July 10, 2001).
Learn More📋Amended Notice of National Institute on Drug Abuse Meeting
The Department of Health and Human Services announces an amended notice for the National Advisory Council on Drug Abuse meeting, scheduled for September 9, 2025. The meeting will feature a change in the virtual access location and will be partially closed to the public, providing details on access through the NIH Videocast. The updated information aims to facilitate public engagement in discussions on drug abuse.
Learn More🐐CDC Rescinds Ban on Haitian Goatskin Handicrafts Importation
Based on a review of existing import requirements, CDC has determined that the import requirements for goatskin handicrafts from Haiti are no longer necessary to protect the public's health and should therefore be rescinded. Accordingly, effective immediately, CDC is rescinding the advisory memorandum order banning the importation of Haitian goatskin handicrafts (August 14, 1981).
Learn More🦠FDA Classifies Multiplex Respiratory Panel for Respiratory Pathogens
The Food and Drug Administration (FDA, the Agency, or we) is classifying the multiplex respiratory panel to detect and identify emerging respiratory pathogen(s) and common respiratory pathogens in human clinical specimens into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the multiplex respiratory panel to detect and identify emerging respiratory pathogen(s) and common respiratory pathogens in human clinical specimens. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.
Learn More🐜Emergency Declaration for New World Screwworm & Business Impact
The Secretary of Health and Human Services (HHS) is issuing this notice pursuant to the Federal Food, Drug, and Cosmetic (FD&C) Act. On August 18, 2025, the Secretary determined, pursuant to his authority under the FD&C Act, that there is a significant potential for a public health emergency that has a significant potential to affect national security or the health and security of United States citizens living abroad and that involves New World Screwworm (Cochliomyia hominivorax) (NWS).
Learn More💰NIH Notice
The Department of Health and Human Services announces closed meetings of the National Institutes of Health's Center for Scientific Review to evaluate grant applications related to cancer research and therapeutics. The meetings, conducted virtually, will involve discussions that could reveal confidential and commercial information, ensuring privacy during the evaluation process.
Learn More🏥Notice of Meeting Change
The Department of Health and Human Services announced a change to the meeting schedule of the Board of Scientific Counselors at the National Institute on Aging. Originally set for three days, the meeting is now scheduled for two days and will be closed to the public.
Learn More🏥Notice of Amended Meeting Logistics for NIH Council of Councils
The Department of Health and Human Services announces an amended notice regarding the Council of Councils meeting, changing its format to virtual and adjusting its schedule and location. The meeting will take place over two days in Bethesda, MD, with specific changes to times and accessibility.
Learn More💰NIH Notice on Grant Review Meetings and Opportunities
The Department of Health and Human Services announces closed meetings held by the Center for Scientific Review at the NIH. These virtual meetings focus on evaluating grant applications across various scientific fields, including cancer research and antibiotic resistance, emphasizing the importance of confidentiality in discussions.
Learn More💊National Advisory Council on Drug Abuse Meeting for Grant Review
The National Advisory Council on Drug Abuse announces a hybrid meeting to evaluate grant applications. The session includes both open and closed portions, discussing confidential information. Interested parties are invited to submit comments, with the meeting set to enhance collaboration on drug abuse research initiatives.
Learn More